Healthcare

House Dem to introduce sweeping drug pricing bill

Rep. Rose DeLauro (D-Conn.) is introducing a new measure to fight back against rising drug prices, an issue that has faced a growing uproar.

{mosads}The bill from DeLauro would create a new intergovernmental Price Review Board, which would have the power to impose penalties on drug companies that it determines “price gouge” consumers. 

The measure, while unlikely to move forward anytime soon due to Republican opposition, is part of a growing movement to do something about rising drug prices. 

DeLauro’s office cites the attention on the more than 400 percent price hike on EpiPens in recent years, an issue that drew concern from both sides of the aisle. 

The review board in DeLauro’s bill would have the power to takes steps including shortening monopolies or imposing fines on companies that it deems to have price gouged. 

Both Hillary Clinton and Donald Trump have called for action on drug prices and the issue is expected to get attention next year. 

More modest measures could have a better chance of passing, such as bipartisan bills to speed up approvals for generic drugs or crack down “pay for delay” arrangements where brand-name manufactures pay for delaying the introduction of a competing generic drug. 

Any drug pricing measures face intense lobbying, however. 

 

 

 

 

 

 

 

 

Tags Donald Trump Hillary Clinton
See all Hill.TV See all Video

Most Popular

Load more

Video

See all Video